News

02/05/2025
New Study from San Raffaele Scientists Featured on the Cover of The EMBO Journal
Congratulations to the teams of Professor Mirela Kuka and Professor Matteo Iannacone, whose paper “T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses” has been featured on the cover of The EMBO Journal.
MORE
18/04/2025
Using lentiviral vectors to vaccinate against liver metastases
Researchers from SR-Tiget have developed a lentiviral vector platform to selectively arm liver and tumor associated macrophages and unleash endogenous T cell-mediated response against liver metastases in preclinical models
MORE
11/04/2025
Parkinson's disease: where are we in the search for new therapies?
On occasion of the World Parkinson's disease day we spoke to Dr. Vania Broccoli, Director of Research at the Institute of Neuroscience of the CNR and Head of the Stem Cells and Neurogenesis Unit at IRCCS Ospedale San Raffaele.
MORE
07/04/2025
SAN RAFFAELE SCIENTIFIC INSTITUTE: GENOME EDITING UNVEILS CELLULAR MECHANISMS AT THE BASIS OF VEXAS SYNDROME. THE HOSPITAL OPENS THE FIRST MULTIDISCIPLINARY CLINIC IN ITALY DEDICATED TO PATIENTS
Researchers from IRCCS San Raffaele Hospital, using an innovative technology of genome editing, have developed a preclinical model that enabled the identification of blood cell poisoning as the main mechanism underlying VEXAS syndrome, an inflammatory disease linked to ageing. Moreover, San Raffaele Hospital opens a multidisciplinary clinic dedicated to patients affected by VEXAS syndrome, becoming a reference center in Italy for its diagnosis and clinical management.
MORE